This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Massachusetts Institute of Technology. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations by Johnathan King in Hair Follicle Stem Cell Propagation
Introduction
Johnathan King is an innovative inventor based in Plano, TX (US). He has made significant contributions to the field of stem cell research, particularly in the propagation of somatic hair follicle stem cells. His work has the potential to revolutionize hair restoration therapies and tissue engineering applications.
Latest Patents
Johnathan King holds a patent for "Methods for ex vivo propagation of somatic hair follicle stem cells." This invention focuses on methods to enhance guanine nucleotide (GNP) biosynthesis, which expands guanine nucleotide pools. By conditionally suppressing asymmetric cell kinetics in explanted cells, his methods provide a pathway for the effective propagation of somatic hair follicle stem cells and melanocyte stem cells. The cultured cells can be utilized in various applications, including hair transplants, gene therapies, and the development of artificial skin.
Career Highlights
Johnathan King is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research in stem cell technology. His work has garnered attention for its innovative approach to cell replacement therapies and regenerative medicine.
Collaborations
Johnathan collaborates with James L. Sherley, a fellow researcher in the field. Their combined expertise enhances the potential for breakthroughs in stem cell applications.
Conclusion
Johnathan King's contributions to the field of stem cell research, particularly through his patented methods for hair follicle stem cell propagation, highlight his role as a leading innovator in regenerative medicine. His work promises to impact various therapeutic applications significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
